Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation.
|
J Exp Med
|
2003
|
3.89
|
2
|
Identity-by-descent filtering of exome sequence data identifies PIGV mutations in hyperphosphatasia mental retardation syndrome.
|
Nat Genet
|
2010
|
3.60
|
3
|
Stroke-induced immunodepression: experimental evidence and clinical relevance.
|
Stroke
|
2007
|
2.76
|
4
|
Terminally differentiated CD8⁺ T cells negatively affect bone regeneration in humans.
|
Sci Transl Med
|
2013
|
2.43
|
5
|
Preventive antibacterial therapy in acute ischemic stroke: a randomized controlled trial.
|
PLoS One
|
2008
|
2.39
|
6
|
Impact of CYP2C9 and CYP2C19 polymorphisms on tolbutamide kinetics and the insulin and glucose response in healthy volunteers.
|
Pharmacogenetics
|
2002
|
1.85
|
7
|
Naturally occurring anti-IFN-gamma autoantibody and severe infections with Mycobacterium cheloneae and Burkholderia cocovenenans.
|
Blood
|
2003
|
1.76
|
8
|
Monitoring temporary immunodepression by flow cytometric measurement of monocytic HLA-DR expression: a multicenter standardized study.
|
Clin Chem
|
2005
|
1.74
|
9
|
Modulation of steady-state kinetics of digoxin by haplotypes of the P-glycoprotein MDR1 gene.
|
Clin Pharmacol Ther
|
2002
|
1.58
|
10
|
Cellular immunodepression preceding infectious complications after acute ischemic stroke in humans.
|
Cerebrovasc Dis
|
2007
|
1.42
|
11
|
Impact of CYP2C9 amino acid polymorphisms on glyburide kinetics and on the insulin and glucose response in healthy volunteers.
|
Clin Pharmacol Ther
|
2002
|
1.42
|
12
|
Stroke propagates bacterial aspiration to pneumonia in a model of cerebral ischemia.
|
Stroke
|
2006
|
1.39
|
13
|
Standardization of whole blood immune phenotype monitoring for clinical trials: panels and methods from the ONE study.
|
Transplant Res
|
2013
|
1.27
|
14
|
No evidence for XMRV in German CFS and MS patients with fatigue despite the ability of the virus to infect human blood cells in vitro.
|
PLoS One
|
2010
|
1.25
|
15
|
Phenotype changes and impaired function of dendritic cell subsets in patients with sepsis: a prospective observational analysis.
|
Crit Care
|
2009
|
1.16
|
16
|
Repulsive guidance molecule-A (RGM-A) inhibits leukocyte migration and mitigates inflammation.
|
Proc Natl Acad Sci U S A
|
2011
|
1.15
|
17
|
Brain antigens in functionally distinct antigen-presenting cell populations in cervical lymph nodes in MS and EAE.
|
J Mol Med (Berl)
|
2008
|
1.14
|
18
|
Regulatory T cells accumulate and proliferate in the ischemic hemisphere for up to 30 days after MCAO.
|
J Cereb Blood Flow Metab
|
2012
|
1.11
|
19
|
Immune responses after acute ischemic stroke or myocardial infarction.
|
Int J Cardiol
|
2010
|
1.08
|
20
|
Heme oxygenase-1 inhibits T cell-dependent skin inflammation and differentiation and function of antigen-presenting cells.
|
Exp Dermatol
|
2007
|
1.02
|
21
|
Influence of stroke localization on autonomic activation, immunodepression, and post-stroke infection.
|
Cerebrovasc Dis
|
2011
|
1.01
|
22
|
Sustained BK viruria as an early marker for the development of BKV-associated nephropathy: analysis of 4128 urine and serum samples.
|
Transplantation
|
2009
|
1.01
|
23
|
Human peripheral blood and bone marrow Epstein-Barr virus-specific T-cell repertoire in latent infection reveals distinct memory T-cell subsets.
|
Eur J Immunol
|
2010
|
1.01
|
24
|
Bronchoalveoloar lavage fluid cytokines and chemokines as markers and predictors for the outcome of interstitial lung disease in systemic sclerosis patients.
|
Arthritis Res Ther
|
2009
|
1.01
|
25
|
MDR1 genotypes do not influence the absorption of a single oral dose of 1 mg digoxin in healthy white males.
|
Br J Clin Pharmacol
|
2002
|
0.99
|
26
|
Influence of CYP2C9 and CYP2D6 polymorphisms on the pharmacokinetics of nateglinide in genotyped healthy volunteers.
|
Clin Pharmacokinet
|
2004
|
0.99
|
27
|
Standardized immune monitoring for the prediction of infections after cardiopulmonary bypass surgery in risk patients.
|
Cytometry B Clin Cytom
|
2003
|
0.99
|
28
|
Impact of the ultrarapid metabolizer genotype of cytochrome P450 2D6 on metoprolol pharmacokinetics and pharmacodynamics.
|
Clin Pharmacol Ther
|
2004
|
0.99
|
29
|
CCN1: a novel inflammation-regulated biphasic immune cell migration modulator.
|
Cell Mol Life Sci
|
2012
|
0.98
|
30
|
Immunodepression after aneurysmal subarachnoid hemorrhage.
|
Stroke
|
2010
|
0.96
|
31
|
Different modes of IL-10 and TGF-beta to inhibit cytokine-dependent IFN-gamma production: consequences for reversal of lipopolysaccharide desensitization.
|
J Immunol
|
2003
|
0.95
|
32
|
Influence of CYP2C9 genetic polymorphisms on pharmacokinetics of celecoxib and its metabolites.
|
Pharmacogenetics
|
2003
|
0.94
|
33
|
Fatal intracerebral mass bleeding associated with Ginkgo biloba and ibuprofen.
|
Atherosclerosis
|
2003
|
0.93
|
34
|
Proteolytically cleaved MLL subunits are susceptible to distinct degradation pathways.
|
J Cell Sci
|
2011
|
0.92
|
35
|
Influence of CYP2C9 polymorphisms on the pharmacokinetics and cholesterol-lowering activity of (-)-3S,5R-fluvastatin and (+)-3R,5S-fluvastatin in healthy volunteers.
|
Clin Pharmacol Ther
|
2003
|
0.90
|
36
|
Protection from brain damage and bacterial infection in murine stroke by the novel caspase-inhibitor Q-VD-OPH.
|
Exp Neurol
|
2007
|
0.89
|
37
|
Analyses of phenotypic and functional characteristics of CX3CR1-expressing natural killer cells.
|
Immunology
|
2011
|
0.89
|
38
|
Nonsteroidal antiinflammatory drugs and a selective cyclooxygenase 2 inhibitor uncouple mitochondria in intact cells.
|
Arthritis Rheum
|
2003
|
0.88
|
39
|
Enantiospecific effects of cytochrome P450 2C9 amino acid variants on ibuprofen pharmacokinetics and on the inhibition of cyclooxygenases 1 and 2.
|
Clin Pharmacol Ther
|
2002
|
0.88
|
40
|
Association of MDR1 genotypes with susceptibility to colorectal cancer in older non-smokers.
|
Eur J Clin Pharmacol
|
2006
|
0.87
|
41
|
The SCIentinel study--prospective multicenter study to define the spinal cord injury-induced immune depression syndrome (SCI-IDS)--study protocol and interim feasibility data.
|
BMC Neurol
|
2013
|
0.86
|
42
|
Mouse strains differ in their susceptibility to poststroke infections.
|
Neuroimmunomodulation
|
2006
|
0.86
|
43
|
Assessment of monocytic HLA-DR expression in ICU patients: analytical issues for multicentric flow cytometry studies.
|
Crit Care
|
2010
|
0.85
|
44
|
Elevation of CD4+ differentiated memory T cells is associated with acute cellular and antibody-mediated rejection after liver transplantation.
|
Transplantation
|
2013
|
0.85
|
45
|
Predicting post-stroke infections and outcome with blood-based immune and stress markers.
|
Cerebrovasc Dis
|
2012
|
0.85
|
46
|
Differential affection of intestinal immune cell populations after cerebral ischemia in mice.
|
Neuroimmunomodulation
|
2009
|
0.85
|
47
|
Superiority of preventive antibiotic treatment compared with standard treatment of poststroke pneumonia in experimental stroke: a bed to bench approach.
|
J Cereb Blood Flow Metab
|
2013
|
0.84
|
48
|
CD31+ naïve Th cells are stable during six months following kidney transplantation: implications for post-transplant thymic function.
|
Am J Transplant
|
2005
|
0.84
|
49
|
Treatment with granulocyte-macrophage colony-stimulating factor is associated with reduced indoleamine 2,3-dioxygenase activity and kynurenine pathway catabolites in patients with severe sepsis and septic shock.
|
Scand J Infect Dis
|
2010
|
0.83
|
50
|
Pharmacokinetics of diclofenac and inhibition of cyclooxygenases 1 and 2: no relationship to the CYP2C9 genetic polymorphism in humans.
|
Br J Clin Pharmacol
|
2003
|
0.82
|
51
|
Microglial activation milieu controls regulatory T cell responses.
|
J Immunol
|
2013
|
0.81
|
52
|
Pharmacogenetics-based new therapeutic concepts.
|
Drug Metab Rev
|
2004
|
0.81
|
53
|
Effects of CYP2C9 polymorphisms on the pharmacokinetics of R- and S-phenprocoumon in healthy volunteers.
|
Pharmacogenetics
|
2004
|
0.81
|
54
|
Polymorphisms of adrenergic receptors and the risk of heart failure.
|
N Engl J Med
|
2003
|
0.81
|
55
|
Differential expression and function of α-mannosidase I in stimulated naive and memory CD4+ T cells.
|
J Immunother
|
2011
|
0.80
|
56
|
Miniaturized bronchoscopy enables unilateral investigation, application, and sampling in mice.
|
Am J Respir Cell Mol Biol
|
2014
|
0.80
|
57
|
Clinical manifestation of mannose-binding lectin deficiency in adults independent of concomitant immunodeficiency.
|
Hum Immunol
|
2009
|
0.80
|
58
|
Alpha-MSH promotes spontaneous post-ischemic pneumonia in mice via melanocortin-receptor-1.
|
Exp Neurol
|
2008
|
0.80
|
59
|
Diminished HLA-DR expression on monocyte and dendritic cell subsets indicating impairment of cellular immunity in pre-term neonates: a prospective observational analysis.
|
J Perinat Med
|
2015
|
0.80
|
60
|
STRoke Adverse outcome is associated WIth NoSocomial Infections (STRAWINSKI): procalcitonin ultrasensitive-guided antibacterial therapy in severe ischaemic stroke patients - rationale and protocol for a randomized controlled trial.
|
Int J Stroke
|
2012
|
0.80
|
61
|
Point-of-care testing for interleukin-6 in cerebro spinal fluid (CSF) after subarachnoid haemorrhage.
|
Med Sci Monit
|
2008
|
0.79
|
62
|
Expression of tolerance associated gene-1, a mitochondrial protein inhibiting T cell activation, can be used to predict response to immune modulating therapies.
|
J Immunol
|
2009
|
0.79
|
63
|
MLL becomes functional through intra-molecular interaction not by proteolytic processing.
|
PLoS One
|
2013
|
0.79
|
64
|
Interleukin-6 serum level assessment using a new qualitative point-of-care test in sepsis: A comparison with ELISA measurements.
|
Clin Biochem
|
2008
|
0.79
|
65
|
Infectious and immunologic phenotype of MECP2 duplication syndrome.
|
J Clin Immunol
|
2015
|
0.78
|
66
|
Discrimination of T-cell subsets and T-cell receptor repertoire distribution.
|
Immunol Res
|
2014
|
0.78
|
67
|
Dysfunction of alveolar macrophages after cardiac surgery and postoperative pneumonia?--An observational study.
|
Crit Care
|
2013
|
0.78
|
68
|
Systematic analysis of sequence variability of the endothelin-1 gene: a prerequisite for association studies.
|
Genet Test
|
2006
|
0.77
|
69
|
IFN-gamma regulation in anti-CD4 antibody-induced T cell unresponsiveness.
|
J Am Soc Nephrol
|
2004
|
0.76
|
70
|
Impaired thymic function and CD4+ T lymphopenia, but not mannose-binding lectin deficiency, are risk factors for Pneumocystis jirovecii pneumonia in kidney transplant recipients.
|
Transpl Immunol
|
2013
|
0.75
|
71
|
Interaction of CA repeat polymorphism of the endothelial nitric oxide synthase and hyperhomocysteinemia in acute coronary syndromes: evidence of gender-specific differences.
|
J Mol Med (Berl)
|
2003
|
0.75
|
72
|
High-mobility group box-1 protein serum levels do not reflect monocytic function in patients with sepsis-induced immunosuppression.
|
Mediators Inflamm
|
2010
|
0.75
|
73
|
Inadequate cytoplasmatic calcium signals in alveolar macrophages after cardiac surgery.
|
Inflamm Res
|
2010
|
0.75
|
74
|
Identification of twelve polymorphisms in the endothelin-1 gene by use of fluorescently labeled oligonucleotides and PCR with restriction fragment polymorphism analysis.
|
Clin Chem
|
2004
|
0.75
|
75
|
Genetic investigations of Saethre-Chotzen syndrome presenting with renal cell carcinoma.
|
Cancer Genet Cytogenet
|
2006
|
0.75
|
76
|
Antibiotic Prophylaxis, Immunoglobulin Substitution and Supportive Measures Prevent Infections in MECP2 Duplication Syndrome.
|
Pediatr Infect Dis J
|
2017
|
0.75
|
77
|
Interpreting Immune Mediator Dysbalance in Sepsis.
|
Crit Care Med
|
2017
|
0.75
|
78
|
Late-Onset Disseminated Mycobacterium avium intracellulare Complex Infection (MAC), Cerebral Toxoplasmosis and Salmonella Sepsis in a German Caucasian Patient with Unusual Anti-Interferon-Gamma IgG1 Autoantibodies.
|
J Clin Immunol
|
2015
|
0.75
|